Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 19:12:1397096.
doi: 10.3389/fpubh.2024.1397096. eCollection 2024.

C-reactive protein point-of-care testing in primary care-broader implementation needed to combat antimicrobial resistance

Affiliations
Review

C-reactive protein point-of-care testing in primary care-broader implementation needed to combat antimicrobial resistance

Carl Llor et al. Front Public Health. .

Abstract

This study presents the perspective of an international group of experts, providing an overview of existing models and policies and guidance to facilitate a proper and sustainable implementation of C-reactive protein point-of-care testing (CRP POCT) to support antibiotic prescribing decisions for respiratory tract infections (RTIs) with the aim to tackle antimicrobial resistance (AMR). AMR threatens to render life-saving antibiotics ineffective and is already costing millions of lives and billions of Euros worldwide. AMR is strongly correlated with the volume of antibiotics used. Most antibiotics are prescribed in primary care, mostly for RTIs, and are often unnecessary. CRP POCT is an available tool and has been proven to safely and cost-effectively reduce antibiotic prescribing for RTIs in primary care. Though established in a few European countries during several years, it has still not been implemented in many European countries. Due to the complexity of inappropriate antibiotic prescribing behavior, a multifaceted approach is necessary to enable sustainable change. The effect is maximized with clear guidance, advanced communication training for primary care physicians, and delayed antibiotic prescribing strategies. CRP POCT should be included in professional guidelines and implemented together with complementary strategies. Adequate reimbursement needs to be provided, and high-quality, and primary care-friendly POCT organization and performance must be enabled. Data gathering, sharing, and discussion as incentivization for proper behaviors should be enabled. Public awareness should be increased, and healthcare professionals' awareness and understanding should be ensured. Impactful use is achieved when all stakeholders join forces to facilitate proper implementation.

Keywords: C-reactive protein; anti-bacterial agents; complementary strategies; drug resistance microbial; implementation; inappropriate prescribing; point-of-care testing; respiratory tract infections.

PubMed Disclaimer

Conflict of interest statement

IG has acted as a consultant for MSD, AbbVie, Gilead, Abbot, Pfizer, GSK, AstraZeneca, Basilea, SOBI, Nordic/InfectoPharm, Angelini, Moderna, Shionogi, and Advanz Pharma t. RH declares to have received honoraria from Abbott, LumiraDx, ShanX Medtech, Future Diagnostics, and Roche for advisory board meetings and lecturing on POCT. Outside the scope of this article, AS has acted as a consultant for Aboca, Angelini, and Novalac; as clinical investigator for Janssen Biologics B.V. and Novalac; speaker for Novartis, Bromatech, Sanofi, and Vyvalife; and was clinical investigator for Aboca, Eli Lilly Cork Limited, and PAREXEL International Srl. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. European Commission (2023). Directorate-general for health and food safety. Tackling antimicrobial resistance in a one health approach, Publications Office of the European Union. Available at: https://data.europa.eu/doi/10.2875/113990 - DOI
    1. European Centre for Disease Prevention and Control (2022). Assessing the health burden of infections with antibiotic-resistant bacteria in the EU/EEA, 2016–2020. Stockholm: ECDC. Available at: https://www.ecdc.europa.eu/en/publications-data/health-burden-infections...
    1. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. . Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. (2022) 399:629–55. doi: 10.1016/S0140-6736(21)02724-0, PMID: - DOI - PMC - PubMed
    1. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. . Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. (2019) 19:56–66. doi: 10.1016/S1473-3099(18)30605-4, PMID: - DOI - PMC - PubMed
    1. United Nations (2020). Global indicator framework for the Sustainable Development Goals and targets of the 2030 Agenda for Sustainable Development. Available at: https://unstats.un.org/sdgs/indicators/Global%20Indicator%20Framework%20...

MeSH terms